However, while some groups are falling ‘short’ on volunteers, others are not accepted into phase III trials. Oxford-AstraZeneca, which is one of the most promising candidate vaccines, is running phase III trials in India as ‘Covishield’. While the tests are receiving an active response from the public, recent reports have …
Read More »